Skip to main content

fluticasone propionate; salmeterol

Generic: FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE·Brand: ADVAIR DISKUS 100/50, ADVAIR DISKUS 250/50, ADVAIR DISKUS 500/50, ADVAIR HFA, AIRDUO DIGIHALER, AIRDUO RESPICLICK, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, WIXELA INHUB

fluticasone propionate; salmeterol: sourced relationships with 1 company · 1 clinical trial tracked · 1 FDA decision.

fluticasone propionate; salmeterol evidence translation

What we can confirm

1 FDA record · 1 tracked trial

What it means

Source-backed records connect fluticasone propionate; salmeterol to TEVA; that link alone does not prove the drug works.

What to watch

Watch active trials and any change in FDA or trial status.
BioSniper AIPage evidence connected

Prepared research question

How could fluticasone propionate; salmeterol → TEVA affect its developer, and what evidence supports the link?

Run cited research

Traceable citations · Unknowns marked

Dated Pipeline Records (1)
CompanyDated record stage
Teva Pharmaceutical Industries Limited (TEVA)
Reported 2017-01-27 · Current development: unknownSource
Approved
Clinical Trial Registry Records (1)

Double-Blinded, Placebo-Controlled, Randomized, 2 Period, Crossover Phase 1/2a Study Testing Safety/Efficacy of Advair HFA (Salmeterol, Fluticasone) in Resting & Exercising Healthy & High Altitude Pulmonary Edema (HAPE) Predisposed Subjects

NCT06040268Registry updated 2025-09-22·Phase 1
Recruiting

Primary endpoint: VO2 max

InterventionalRandomizedquadruple60 targetStarted 2023-12Completion 2026-121 site · United StatesUniversity of Colorado, Denver
FDA Decisions1 records
Approval(TEVA)FDA ↗
NDA208799Type 4 - New CombinationStandardInhalationPowder

Frequently asked questions

Which companies have sourced relationships with fluticasone propionate; salmeterol?

fluticasone propionate; salmeterol has dated SEC/FDA relationship records for Teva Pharmaceutical Industries Limited.

How many clinical trials involve fluticasone propionate; salmeterol?

BioSniper tracks 1 clinical trial involving fluticasone propionate; salmeterol.

What is fluticasone propionate; salmeterol's latest FDA decision?

The most recent tracked FDA decision for fluticasone propionate; salmeterol is Approval, dated January 27, 2017.